MCY vs MRCY: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: MCY is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. MCY and MRCY share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined MCY and MRCY exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Mercury General Corporation, founded by George Joseph in 1961 and still headquartered on Wilshire Boulevard in Los Angeles, is the parent of Mercury Casualty, Mercury Insurance Company and related carriers. It sells private passenger auto, homeowners, renters, umbrella and small commercial auto cover in eleven states, though the business is not geographically balanced: California private passenger auto was about 53% of net premiums earned in the first half of 2026 and California homeowners another 18%. Distribution runs almost entirely through independent agents rather than direct advertising, which keeps acquisition costs different in shape from a Progressive or a GEICO, and the company carried roughly 2.36 million policies in force at mid-2026 (about 1.07 million auto, about 938 thousand homeowners). Joseph remains chairman and holds roughly a third of the shares, so control sits with the founding family rather than with institutions.

Full MCY guide

Mercury Systems, based in Andover, Massachusetts, designs and manufactures hardware, software, and integrated subsystems that sit inside US and allied defense platforms. Its portfolio spans radio-frequency and microwave components, digital signal processing boards, embedded and secure processing modules, and fully integrated sensor-processing subsystems used in radar, electronic warfare, signals intelligence, missiles, and unmanned systems. The company positions itself as a trusted, domestically sourced supplier of open-architecture processing, sitting one layer below the large prime contractors that build the finished aircraft, ships, and weapons.

Full MRCY guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• MCY drivers: Approved California rate increases still earning in; A rebuilt catastrophe reinsurance tower.
• MRCY drivers: Record bookings and backlog; Margin recovery and turnaround execution.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Concentration is the first risk and it is structural, not cyclical: with roughly 70% of net premiums earned coming from two California lines, one bad fire season can erase several good underwriting years, as 2025's record $508 million of net catastrophe losses and 105.4% first half combined ratio demonstrated. For MRCY, mercury is still early in a turnaround and has reported GAAP net losses as recently as fiscal 2025, so profitability remains inconsistent.

Pick MCY if you believe its drivers more; MRCY if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the MCY and MRCY guides.

MCY. Second quarter net income of roughly $263.5 million (about $4.76 per diluted share) included roughly $86.5 million of realized investment gains, so operating income of about $195.2 million, or roughly $3.52 per share, is the cleaner read on underwriting. A combined ratio under 90% on a personal lines book is unusually profitable, which is why the shares carry about 2.1 times book rather than the 1.0 to 1.3 times more common for a California-concentrated insurer. Whether that multiple is durable depends on catastrophe load: strip 2025's 9.2 points of catastrophe losses out or add them back, and the same company looks like two different businesses.

MRCY. Mercury trades at a rich multiple of revenue for its size, reflecting investor expectations that the turnaround converts a large backlog into higher-margin, cash-generative earnings rather than trailing profits, which have been near breakeven. GAAP results still swing around losses, so traditional price-to-earnings is of limited use and much of the valuation debate centers on adjusted EBITDA and free cash flow. The stock traded roughly in the low-100s per share in mid-July 2026, well above its levels of a year earlier, with a reported beta below the market average near 0.84.

Headline figures (approximate, August 2026): MCY shows revenue (ttm) ~$6.3B, net premiums earned (q2 2026) ~$1.50B, up ~9.6% year over year, combined ratio (q2 2026) ~89.9% vs ~92.5% a year earlier, book value per share ~$51.20 at June 30, 2026 vs ~$43.64 at year-end 2025; MRCY shows revenue (ttm) ~$943M, fy2025 revenue ~$912M (vs ~$835M FY2024), q3 fy2026 revenue ~$236M (+11.5% organic YoY), backlog ~$1.6B (record, +18% YoY).

MCY and MRCY are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined MCY and MRCY exposure against your real portfolio. It is not an investment adviser.